- Home
- SDST vs SNTI Comparison
SDST vs SNTI Comparison
Compare SDST & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDST
- SNTI
- Stock Information
- Founded
- SDST 2022
- SNTI 2016
- Country
- SDST United States
- SNTI United States
- Employees
- SDST N/A
- SNTI N/A
- Industry
- SDST Blank Checks
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- SDST Finance
- SNTI Health Care
- Exchange
- SDST Nasdaq
- SNTI Nasdaq
- Market Cap
- SDST 37.0M
- SNTI 39.6M
- IPO Year
- SDST N/A
- SNTI N/A
- Fundamental
- Price
- SDST $0.41
- SNTI $1.60
- Analyst Decision
- SDST Buy
- SNTI Strong Buy
- Analyst Count
- SDST 2
- SNTI 2
- Target Price
- SDST $1.70
- SNTI $8.50
- AVG Volume (30 Days)
- SDST 3.4M
- SNTI 140.6K
- Earning Date
- SDST 08-13-2025
- SNTI 08-07-2025
- Dividend Yield
- SDST N/A
- SNTI N/A
- EPS Growth
- SDST N/A
- SNTI N/A
- EPS
- SDST N/A
- SNTI N/A
- Revenue
- SDST N/A
- SNTI N/A
- Revenue This Year
- SDST N/A
- SNTI N/A
- Revenue Next Year
- SDST $246.67
- SNTI $150.00
- P/E Ratio
- SDST N/A
- SNTI N/A
- Revenue Growth
- SDST N/A
- SNTI N/A
- 52 Week Low
- SDST $0.14
- SNTI $1.46
- 52 Week High
- SDST $12.56
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- SDST N/A
- SNTI 37.49
- Support Level
- SDST N/A
- SNTI $1.51
- Resistance Level
- SDST N/A
- SNTI $1.62
- Average True Range (ATR)
- SDST 0.00
- SNTI 0.11
- MACD
- SDST 0.00
- SNTI 0.01
- Stochastic Oscillator
- SDST 0.00
- SNTI 35.00
About SDST Stardust Power Inc. Common Stock
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.